In vitro studies on controlled‐release cellulose acetate films for local delivery of chlorhexidine, indomethacin, and meloxicam

Journal of Clinical Periodontology - Tập 31 Số 12 - Trang 1117-1121 - 2004
Emel Öykü Çetin1, Nurcan Buduneli2, Evren Atlıhan3, Levent Kırılmaz3
1Department of Biopharmaceutics and Pharmacokinetics, School of Pharmacy, Ege University, Izmir, Turkey.
2Department of Periodontology, School of Dentistry, Ege University, İzmir, Turkey
3Department of Biopharmaceutics and Pharmacokinetics, School of Pharmacy

Tóm tắt

AbstractBackground: Delivery of medications into periodontal pockets to suppress or eradicate the pathogenic microbiota or modulate the inflammatory response, thereby limiting periodontal tissue destruction, has attracted significant interest with the purpose of effective periodontal treatment. However, no study has previously attempted to develop a controlled‐release formulation of anti‐inflammatory agents to be used in the field of periodontology. The aim of the present study was to examine the in vitro release profile of chlorhexidine gluconate, indomethacin, and meloxicam from cellulose acetate films.Methods: Cellulose acetate films containing chlorhexidine gluconate, indomethacin, and meloxicam were prepared and cut in a form to fit to the periodontal pocket anatomy. The release of active agents was studied in 10 ml artificial saliva at 37°C. Apparatus Vibrax was used at 150 r.p.m. Determinations were carried out spectrophotometrically and the release profiles were plotted as a function of time.Results: The formulations showed two different release patterns for a total observation period of approximately 120 h. When the formulations of the three active agents were compared, the release patterns of meloxicam and chlorhexidine gluconate were found to be similar, while the indomethacin‐containing formulation exhibited the fastest release rate.Conclusions: As a conclusion, cellulose acetate may be a suitable inert material for obtaining a prolonged local release of various anti‐inflammatory agents like meloxicam. Further in vitro and in vivo studies are required before starting clinical applications of these controlled‐release formulations of anti‐inflammatory agents.

Từ khóa


Tài liệu tham khảo

10.1902/jop.1982.53.11.693

10.1902/annals.1999.4.1.1

10.1902/jop.2000.71.6.1009

Buduneli N., 2001, Preparation of a controlled‐release formulation of chlorhexidine gluconate, Ankara Üniversitesi Dişhekimliği Fakültesi Dergisi, 28, 287

Buduneli N., 2001, Gingival crevicular fluid levels of IL‐4, IL‐6, IFN‐γ and TGF‐β1 following adjunctive use of meloxicam and initial periodontal therapy, Ankara Üniversitesi Dişhekimliği Fakültesi Dergisi, 28, 161

10.1902/jop.2002.73.1.103

10.1093/rheumatology/35.suppl_1.4

Fiorellini J. P., 1992, The potential role of controlled release delivery systems for chemotherapeutic agents in periodontics, Journal of Periodontology, 66, 870

Garito M. L., 1995, Salivary PAF levels correlate with severity of periodontal inflammation, Journal of Dentistry, 74, 1048

Goffin G., 1998, Efficacy of a sustained local delivery of chlorhexidine Periochip as an adjunct to scaling and root planning in the treatment of chronic periodontal disease, International Dental Reviews, 1

Goodson J., 1989, Pharmacokinetic principles controlling efficacy of oral therapy, Journal of Dental Research, 68, 625

10.1902/jop.1983.54.10.575

10.1111/j.1600-051X.1988.tb01011.x

10.1111/j.1600-0757.1994.tb00020.x

10.1111/j.1600-051X.2001.280114.x

10.1111/j.1600-0765.1988.tb01617.x

10.1016/S0300-5712(96)00045-0

10.1021/js9505253

10.1111/j.1600-051X.1984.tb01328.x

Marsh P. D., 1989, Host defences and microbial homeostasis, Journal of Dental Research, 68, 1567

10.1067/moe.2001.115127

10.1111/j.1600-0765.1986.tb01443.x

10.1002/1529-0131(199910)12:5<351::AID-ART7>3.0.CO;2-L

10.1016/S0168-3659(97)00158-2

10.1016/S0378-5173(98)00271-3

10.1034/j.1600-0757.2002.280104.x

10.1111/j.1600-051X.1993.tb00708.x

10.1007/BF00237817

10.1016/S0885-3924(02)00410-4

10.1177/10454411970080020501

10.1111/j.1600-051X.1998.tb02407.x

10.1111/j.1600-051X.1979.tb01935.x

10.1111/j.1600-051X.1989.tb01651.x

Williams R. C., 1991, Three‐year trial of flurbiprofen treatment in humans‐post treatment period, Journal of Dental Research, 70, 468

10.14219/jada.archive.2003.0284